LEBRIKIZUMAB-LBKZ

2280 reported adverse events

Drug classes: Interleukin-13 Antagonist [EPC]

These side effects are most commonly reported by patients taking LEBRIKIZUMAB-LBKZ:

# Side effect Count
0 PRURITUS 264
1 INJECTION SITE PAIN 260
2 DRUG INEFFECTIVE 241
3 RASH 178
4 CONJUNCTIVITIS 154
5 DERMATITIS ATOPIC 149
6 ECZEMA 135
7 ERYTHEMA 109
8 DRY SKIN 79
9 INCORRECT DOSE ADMINISTERED 72
See all common reactions for LEBRIKIZUMAB-LBKZ

LEBRIKIZUMAB-LBKZ is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONJUNCTIVITIS 154 0.0083
1 CUTANEOUS T-CELL LYMPHOMA 10 0.0079
2 PERIORAL DERMATITIS 4 0.0063
3 INJECTION SITE EXFOLIATION 4 0.0060
4 ECZEMA EYELIDS 3 0.0054
5 VITILIGO 7 0.0030
6 DERMATITIS ATOPIC 149 0.0028
7 EYELID MARGIN CRUSTING 8 0.0028
8 ECZEMA 135 0.0026
9 EYELID IRRITATION 6 0.0024
See all enriched reactions for LEBRIKIZUMAB-LBKZ